Revenue from the core Skin Care business amounted to around DKK 400 million in FY 2023/24, with an operating profitability level significantly below the group EBIT margin. Coloplast’s FY 2024/25 ...

as well as costs tied to the Urology recall and skin care exit. The best parts of the Coloplast story remain the company’s strong share in decent markets (35%-plus share in Ostomy, a market ...

Coloplast A/S engages in the development and ... brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal ...